Entera Bio - ENTX Earnings per share for the trailing year

Public company logo of Entera Bio Corp (ENTX)

The market trend for Entera Bio Ltd. (ENTX) shown on this price chart reflects EPS TTM dynamics at -59.60. Entera Bio Ltd. (ENTX) is implementing eco-friendly production methods for oral medications while adhering to bioethical management standards. Future revenue relies on patents and licensing deals with industry behemoths. The success of these developments is driven by highly qualified biochemists creating innovative protein delivery methods.

Entera Bio (ENTX): Earnings per share for the last twelve months from 02/11/2024 to 11/15/2026

ENTX (Entera Bio Ltd): analytical breakdowns and indicator data

- stock price and consensus target price:
Price enterabio.com|ENTX - Analyst Consensus Forecast
- issuer market value details:
Market Value Entera Bio Corp|ENTX - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Entera Bio|ENTX - Company Book Value|Market Value to Book Value enterabio.com|ENTX - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Entera Bio Ltd.|ENTX - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Entera Bio Ltd|ENTX - Company Total Debt|Debt to Book Capital Entera Bio Corp|ENTX - Company Long-Term Debts|Short-Term Debt Entera Bio|Intermediate Coverage Ratio enterabio.com
- net income and valuation ratios data:
ENTX - Net Profit|Projected Future Earnings Entera Bio Ltd.|ENTX - Price to Earnings Ratio|Future Price to Earnings Multiple enterabio.com|ENTX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Entera Bio Corp|ENTX - Operating profit EBITDA|Net earnings per share for the last four quarters Entera Bio|ENTX - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months enterabio.com|ENTX - Net earnings per share growth this year|Expected earnings per share trend next year Entera Bio Ltd.
- revenue and sales details:
ENTX - Company Revenue|Company Projected Revenue Entera Bio Ltd|ENTX - Market Cap to Revenue|Price to Expected Revenue Ratio Entera Bio Corp
Fundamental valuation:Entera Bio Ltd (ENTX)
Core merchandise of Entera Bio

This indicator captures the rate of change in net earnings per share over a rolling year, stripping the financial result of seasonal distortions to reveal the true profitability trend. By analyzing the current EPS YoY TTM dynamics, an investor can see the scaling efficiency of the Entera Bio (ENTX) licensing platform, where royalty growth from pharma behemoths at minimal cost converts directly into the capitalization of each share.

Competitor analysis for Entera Bio Ltd.

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HYFT|ABVC (ABVC BioPharma Inc) - Earnings per share for the trailing year|Cumberland Pharmaceuticals - Net earnings per share for the last 12 months|quantumbiopharma.com (QNTM) - Net earnings per one share for the last twelve months|FibroGen Inc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TELO (Telomir Pharmaceuticals Inc)|RANI (Rani Therapeutics Holdings, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Synergy CHC Corporation|Earnings per share for the last twelve months Rallybio Corp|Lexaria Bioscience (LEXX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|Net earnings per share for the last four quarters Pheton|Earnings per share for the last twelve months Aptorum Group Limited APM|LYRA - Net earnings per share for the last 12 months|IBO: Net earnings per share for the last 12 months|TNFA - Net earnings per share (EPS TTM)|cbdMD Corp (YCBD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRFX (PainReform Limited)|CYTO (Altamira Therapeutics Ltd.) - Net earnings per share (EPS TTM)|Lipella (LIPO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OPTN|Net earnings per share (EPS TTM) pieris.com (PIRS)|Earnings per share for the last twelve months Procaps Group Corp PROC|Petros Pharmaceuticals Inc - Earnings per share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months